John Fitzgerald Traverse

This inventor holds 31 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Celgene Corporation, Celgene Car LLC, Signal Pharmaceuticals, Inc.. Active years: 2014-2026.

USPTO Granted Patents = 31 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 63(Granted Patents)

Location History:

Union, NJ (US) (2015)
Roselle Park, NJ (US) (2014 - 2019)
Summit, NJ (US) (2023)
Lebanon, NJ (US) (2018 - 2024)

Company Filing History:

Signal Pharmaceuticals, Inc.

patents

4. 2 out of 108

Celgene Quanticel Research, Inc.

patents

5. 1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2014-2026

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12729183 - Process for the preparation of bromodomain inhibitor (2026-09-08),

2. 12435028 - Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate (2025-10-07),

3. 12343346 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same (2025-07-01),

4. 12227519 - Preparation of maytansinol (2025-02-18),

5. 11912644 - Processes for the preparation of ()-tert-butyl 4,5-diamino-5-oxopentanoate (2024-02-27),

6. 11655257 - MK2 inhibitors, synthesis thereof, and intermediates thereto (2023-05-23),

7. 11566004 - Process for the preparation of bromodomain inhibitor (2023-01-31),

8. 11505522 - Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate (2022-11-22),

9. 11241439 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same (2022-02-08),

10. 11014940 - Thiazolidinone and oxazolidinone compounds and formulations (2021-05-25),

11. 10894796 - MK2 inhibitors, synthesis thereof, and intermediates thereto (2021-01-19),

12. 10717703 - Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate (2020-07-21),

13. 10646503 - Isotopologues of 5-azacytidine (2020-05-12),

14. 10596180 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same (2020-03-24),

15. 10463683 - Isotopologues of 5-azacytidine (2019-11-05),

Title: John Fitzgerald Traverse - Pioneering Inventor from Lebanon, NJ

Introduction: John Fitzgerald Traverse is a renowned inventor hailing from Lebanon, NJ, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: John Fitzgerald Traverse holds several patents in the areas of renewable energy, sustainable agriculture, and advanced robotics, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the industry, John has worked with leading research institutions and universities to develop cutting-edge technologies that have revolutionized their respective fields.

Collaborations: Throughout his career, John has collaborated with top companies, innovative startups, and talented individuals to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: John Fitzgerald Traverse's passion for pushing the boundaries of what is possible through innovation continues to inspire the next generation of inventors and shape the future of technology.